Rob Steendam

854 citations
35 papers · 726 · h-index 19

Impact in

    • Advanced Drug Delivery Systems
    • Drug Solubulity and Delivery Systems
    • Electrospun Nanofibers in Biomedical Applications
    • biodegradable polymer synthesis and properties
    • Nanoparticle-Based Drug Delivery

Papers in

    • Advanced Drug Delivery Systems 10
    • Drug Solubulity and Delivery Systems 4
    • biodegradable polymer synthesis and properties 5
    • Electrospun Nanofibers in Biomedical Applications 4

Rob Steendam

35 papers receiving 703 citations

Peers

Rob Steendam
Comparison fields: 5 of 94
  • Pharmaceutical Science 191
  • Biomaterials 237
  • Molecular Medicine 40
  • Biomedical Engineering 175
  • Surgery 129
Replace Keiji Fujioka with:
Keiji Fujioka Japan
Husam M. Younes Qatar
Agata Ładniak Poland
Yifan Song China
Morgan V. Fedorchak United States
Jau‐Min Wong Taiwan
Johan Zuidema Netherlands
Jin Lee South Korea
T. V. Kumary India
Yong Woo Cho South Korea
Rob Steendam relative to Keiji Fujioka Japan Keiji Fujioka's profile →
Citations per field
00.5×6.6×
Keiji Fujioka · 1×
Citations per year

Countries citing papers authored by Rob Steendam

Since Specialization
Citations

This map shows the geographic impact of Rob Steendam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Steendam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Steendam more than expected).

Fields of papers citing papers by Rob Steendam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob Steendam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Steendam. The network helps show where Rob Steendam may publish in the future.

Co-authors

The 25 scholars most cited alongside Rob Steendam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rob Steendam Line = papers co-authored together Rob Steendam links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#Work
1 200162
2 201455
3 200346
4 201443
5 202141
6 201340
7 201539
8 200137
9 201433
10 201927
11 200027
12 201726
13 199825
14 201623
15 201722
16 202020
17 201020
18 199619
19 201918
20 201914

About Rob Steendam

Rob Steendam is a scholar working on Pharmaceutical Science, Biomaterials, Surgery, Biomedical Engineering and Cardiology and Cardiovascular Medicine, having authored 35 papers that have together received 726 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (10 papers), biodegradable polymer synthesis and properties (5 papers), Drug Solubulity and Delivery Systems (4 papers), Electrospun Nanofibers in Biomedical Applications (4 papers), Tissue Engineering and Regenerative Medicine (4 papers), Pancreatic function and diabetes (3 papers), Cardiac Fibrosis and Remodeling (3 papers) and Osteoarthritis Treatment and Mechanisms (2 papers). The work is most often cited by research in Pharmaceutical Science (191 citations), Biomaterials (237 citations), Molecular Medicine (40 citations), Biomedical Engineering (175 citations) and Surgery (129 citations). Rob Steendam has collaborated with scholars based in Netherlands, Ireland and United States. Frequent co-authors include Henderik W. Frijlink, C.F. Lerk, Wouter L.J. Hinrichs, Wim E. Hennink, Johan Zuidema, Christine Hiemstra, Milica Stanković, Mies J. van Steenbergen, Robbert J. Kok and Marcel F. Meek. Their work appears in journals such as Journal of Controlled Release, International Journal of Pharmaceutics, Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics and European Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact